{{Rsnum
|rsid=9826507
|Chromosome=3
|position=137072544
|Orientation=plus
|GMAF=0.3049
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{PharmGKB
|RSID=rs9826507
|Name_s=
|Gene_s=-
|Feature=
|Evidence=PubMed ID:19084216
|Annotation=In a case-control study of Type I Diabetes Mellitus patients from Finland, Iceland and the British Isles, the G allele of rs9826507 was associated with risk of Diabetic Nephropathy . This SNP was part of a risk haplotype consisting of rs62408925 T, rs9826507G and rs1866813 C.
|Drugs=
|Drug Classes=
|Diseases=Diabetes Mellitus, Type 1; Diabetic Nephropathies
|Curation Level=Curated
|PharmGKB Accession ID=PA164857072
}}

{{GET Evidence
|impact=pharmacogenetic
|qualified_impact=Insufficiently evaluated pharmacogenetic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs9826507
|overall_frequency_n=48
|overall_frequency_d=120
|overall_frequency=0.4
|n_genomes=31
|n_genomes_annotated=0
|n_haplomes=40
|n_articles=1
|n_articles_annotated=0
|in_pharmgkb=Y
|autoscore=1
|webscore=N
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}